Monogram Orthopaedics Common Stock Today
| MGRM Stock | 2.80 0.03 1.08% |
Performance7 of 100
| Odds Of DistressLess than 47
|
Monogram Orthopaedics is selling at 2.80 as of the 30th of January 2025; that is 1.08 percent up since the beginning of the trading day. The stock's lowest day price was 2.71. Monogram Orthopaedics has 47 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 2nd of October 2024 and ending today, the 30th of January 2025. Click here to learn more.
Moving against Monogram Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Monogram Stock Highlights
| President Board | Benjamin CFA |
| Thematic Idea | Medical Equipment (View all Themes) |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
| Financial Strength | |
Monogram Orthopaedics Common (MGRM) is traded on NASDAQ Exchange in USA. It is located in 3913 Todd Lane, Austin, TX, United States, 78744 and employs 28 people. Monogram Orthopaedics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 95.05 M. Monogram Orthopaedics conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 34.31 M outstanding shares of which 174.69 K shares are now shorted by private and institutional investors with about 3.0 trading days to cover.
Monogram Orthopaedics generates negative cash flow from operations
Check Monogram Orthopaedics Probability Of Bankruptcy
Ownership AllocationMonogram Orthopaedics maintains a total of 34.31 Million outstanding shares. Monogram Orthopaedics Common holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Monogram Ownership Details
Monogram Orthopaedics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Monogram Orthopaedics market risk premium is the additional return an investor will receive from holding Monogram Orthopaedics long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0913 | |||
| Jensen Alpha | 0.4277 | |||
| Total Risk Alpha | 0.0316 | |||
| Sortino Ratio | 0.0818 |
Monogram Stock Against Markets
Monogram Orthopaedics Corporate Executives
Elected by the shareholders, the Monogram Orthopaedics' board of directors comprises two types of representatives: Monogram Orthopaedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Monogram. The board's role is to monitor Monogram Orthopaedics' management team and ensure that shareholders' interests are well served. Monogram Orthopaedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Monogram Orthopaedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Unis | Chief Founder | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.